MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ

Biochemical and Biophysical Research Communications

Volumn 457, Issue 2, 2015, Pages 171-176

  Yuan, Jian ^a,b   Xiao, Gelei ^a,b   Peng, Gang ^a   Liu, Dingyang ^a,b   Wang, Zeyou ^c   Liao, Yiwei ^a,b   Liu, Qing ^a,b   Wu, Minghua ^b,c   Yuan, Xianrui ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The Institute of Skull Base Surgery and Neurooncology at Hunan Changsha 410008   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell differentiation; Glioblastoma; MiR 125a 5p; TAZ

Indexed keywords

MICRORNA; MICRORNA 125A 5P; TAZ PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MESSENGER RNA; MIRN125 MICRORNA, HUMAN; TAZ PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; GLIOMA CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TARGETING; BRAIN TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; TUMOR GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84921817677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.078     Document Type: Article

References (27)

1. C.D. Katsetos, E. Draberova, B. Smejkalova, G. Reddy, L. Bertrand, J.P. de Chadarevian, A. Legido, J. Nissanov, P.W. Baas, P. Draber, Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells, Neurochem. Res. 32 (2007) 1387-1398.
2. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, H.I. Kornblum, Cancerous stem cells can arise from pediatric brain tumors, Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15178-15183.
3. B.B. Zhou, H. Zhang, M. Damelin, K.G. Geles, J.C. Grindley, P.B. Dirks, Tumourinitiating cells: challenges and opportunities for anticancer drug discovery, Nat. Rev. Drug Discov. 8 (2009) 806-823.
4. Q.Y. Lei, H. Zhang, B. Zhao, Z.Y. Zha, F. Bai, X.H. Pei, S. Zhao, Y. Xiong, K.L. Guan, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway, Mol. Cell. Biol. 28 (2008) 2426-2436.
5. C.Y. Liu, Z.Y. Zha, X. Zhou, H. Zhang, W. Huang, D. Zhao, T. Li, S.W. Chan, C.J. Lim, W. Hong, S. Zhao, Y. Xiong, Q.Y. Lei, K.L. Guan, The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase, J. Biol. Chem. 285 (2010) 37159-37169.
6. H.F. Yuen, C.M. McCrudden, Y.H. Huang, J.M. Tham, X. Zhang, Q. Zeng, S.D. Zhang, W. Hong, TAZ expression as a prognostic indicator in colorectal cancer, PLoS One 8 (2013) e54211.
7. A.N. Lau, S.J. Curtis, C.M. Fillmore, S.P. Rowbotham, M. Mohseni, D.E. Wagner, A.M. Beede, D.T. Montoro, K.W. Sinkevicius, Z.E. Walton, J. Barrios, D.J. Weiss, F.D. Camargo, K.K. Wong, C.F. Kim, Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis, EMBO J. 33 (2014) 468-481.
8. S.W. Chan, C.J. Lim, K. Guo, C.P. Ng, I. Lee, W. Hunziker, Q. Zeng, W. Hong, A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells, Cancer Res. 68 (2008) 2592-2598.
9. Z. Zhou, Y. Hao, N. Liu, L. Raptis, M.S. Tsao, X. Yang, TAZ is a novel oncogene in non-small cell lung cancer, Oncogene 30 (2011) 2181-2186.
10. M. Xie, L. Zhang, C.S. He, J.H. Hou, S.X. Lin, Z.H. Hu, F. Xu, H.Y. Zhao, Prognostic significance of TAZ expression in resected non-small cell lung cancer, J. Thorac. Oncol. 7 (2012) 799-807.
11. M. Cordenonsi, F. Zanconato, L. Azzolin, M. Forcato, A. Rosato, C. Frasson, M. Inui, M. Montagner, A.R. Parenti, A. Poletti, M.G. Daidone, S. Dupont, G. Basso, S. Bicciato, S. Piccolo, The Hippo transducer TAZ confers cancer stem cellrelated traits on breast cancer cells, Cell 147 (2011) 759-772.
12. J.S. Mo, H.W. Park, K.L. Guan, The Hippo signaling pathway in stem cell biology and cancer, EMBO Rep. 15 (2014) 642-656.
13. K.P. Bhat, K.L. Salazar, V. Balasubramaniyan, K. Wani, L. Heathcock, F. Hollingsworth, J.D. James, J. Gumin, K.L. Diefes, S.H. Kim, A. Turski, Y. Azodi, Y. Yang, T. Doucette, H. Colman, E.P. Sulman, F.F. Lang, G. Rao, S. Copray, B.D. Vaillant, K.D. Aldape, The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma, Genes Dev. 25 (2011) 2594-2609.
14. M. Chekulaeva, W. Filipowicz, Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells, Curr. Opin. Cell Biol. 21 (2009) 452-460.
15. N. Bushati, S.M. Cohen, MicroRNA functions, Annu. Rev. Cell Dev. Biol. 23 (2007) 175-205.
16. B. Zhang, X. Pan, G.P. Cobb, T.A. Anderson, MicroRNAs as oncogenes and tumor suppressors, Dev. Biol. 302 (2007) 1-12.
17. H.W. Hwang, J.T. Mendell, MicroRNAs in cell proliferation, cell death, and tumorigenesis, Br. J. Cancer 94 (2006) 776-780.
18. N. Nishida, K. Mimori, M. Fabbri, T. Yokobori, T. Sudo, F. Tanaka, K. Shibata, H. Ishii, Y. Doki, M. Mori, MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab, Clin. Cancer Res. 17 (2011) 2725-2733.
19. J.K. Kim, J.H. Noh, K.H. Jung, J.W. Eun, H.J. Bae, M.G. Kim, Y.G. Chang, Q. Shen, W.S. Park, J.Y. Lee, J. Borlak, S.W. Nam, Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors miR-125a-5p and miR-125b, Hepatology 57 (2013) 1055-1067.
20. M.A. Cortez, M.S. Nicoloso, M. Shimizu, S. Rossi, G. Gopisetty, J.R. Molina, C. Carlotti Jr., D. Tirapelli, L. Neder, M.S. Brassesco, C.A. Scrideli, L.G. Tone, M.M. Georgescu, W. Zhang, V. Puduvalli, G.A. Calin, MiR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma, Genes Chromosomes Cancer 49 (2010) 981-990.
21. D.C. Altieri, New wirings in the survivin networks, Oncogene 27 (2008) 6276-6284.
22. L. Qiang, T. Wu, H.W. Zhang, N. Lu, R. Hu, Y.J. Wang, L. Zhao, F.H. Chen, X.T. Wang, Q.D. You, Q.L. Guo, HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway, Cell Death Differ. 19 (2012) 284-294.
23. L. Azzolin, F. Zanconato, S. Bresolin, M. Forcato, G. Basso, S. Bicciato, M. Cordenonsi, S. Piccolo, Role of TAZ as mediator of Wnt signaling, Cell 151 (2012) 1443-1456.
24. D. Xie, D. Yin, H.J. Wang, G.T. Liu, R. Elashoff, K. Black, H.P. Koeffler, Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas, Clin. Cancer Res. 10 (2004) 2072-2081.
25. J.L. Fox, M. Dews, A.J. Minn, A. Thomas-Tikhonenko, Targeting of TGFb signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma, RNA 19 (2013) 177-190.
26. A. Chakravarti, E. Noll, P.M. Black, D.F. Finkelstein, D.M. Finkelstein, N.J. Dyson, J.S. Loeffler, Quantitatively determined survivin expression levels are of prognostic value in human gliomas, J. Clin. Oncol. 20 (2002) 1063-1068.
27. A. Chakravarti, G.G. Zhai, M. Zhang, R. Malhotra, D.E. Latham, M.A. Delaney, P. Robe, U. Nestler, Q. Song, J. Loeffler, Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms, Oncogene 23 (2004) 7494-7506.